New Ask Claude or ChatGPT about any stock, using Bullpen. Bullpen in Claude or ChatGPT. 7 days free

Thursday, November 19, 2026

Back to the front page

From X

Convequity on X

Lumentum ($LITE) and Coherent ($COHR) have pricing power because lasers are scarce. In our view that scarcity may not last, because competition is coming from four sides. First, shared lasers. With optical amplifiers, one laser can feed several channels, and designers can add amplification where it is needed instead of relying on one high-power laser. That could mean fewer lasers sold per unit of bandwidth, or less demand for the highest-power products. The second risk falls mainly on Lumentum, because ultra-high-power CW lasers are now its core business. Second, new architectures for short links. MicroVCSEL designs spread bandwidth across many small, slower lasers. MicroLEDs go further and replace lasers altogether in suitable applications. Third, LiDAR companies are bringing their laser and amplifier know-how into data centres. Aeva ($AEVA) announced an amplifier with reported output above 630 mW and a joint development agreement for a major hyperscaler's deployment. MicroVision ($MVIS) introduced an external laser module for co-packaged optics and says it is in talks with potential licensees and development partners. Fourth, making standard 100 mW CW lasers is fairly commoditized know-how, and many companies are trying to scale up production, including Semtech ($SMTC), Sivers, Nokia ($NOK) and MACOM ($MTSI). Total optical revenue at both incumbents could still grow as networks expand. The risk is that customers gain more ways to obtain the light they need, which would weaken the pricing power that comes from scarce lasers.

S&P Global

S&P Global’s valuation swung from 7x earnings in 2009 to 50x in 2024 as ratings, indices and proprietary data expanded through acquisitions…

PYPL · long

Paypal Holdings INC

PayPal’s valuation implies free cash flow will shrink 9.3% annually over the next decade, framing a long thesis against its recent revenue…

Research Roundup Vol. XLIX

Research Roundup Vol. XLIX covers 3.4% inflation, AI compute demand, data center buildouts, and Q2 reports from Rocket Lab, CoreWeave,…

Boston Scientific (BSX): New Position

Boston Scientific’s Farapulse competition and weaker Watchman demand have slowed growth, prompting a $2 billion buyback, restructuring and…

Revisiting Veeva #2

Veeva plans Falcon agents for pharmacovigilance, clinical-trial documents and regulatory writing, targeting multibillion-dollar…

Over Target

Ukraine’s Black Sea attacks on CPC infrastructure threaten Kazakhstan’s 1.4 million bpd oil export route through Russia, putting Chevron’s…

Publications we follow

Every publication on this site, hand-picked.

130 publications

Newsletters 110

Seeking Alpha 97 of 301

X accounts we follow

Every account on this site, hand-picked.

94 accounts

Investor letters we follow

383 firms

Sectors

Ordered by how often our editor reaches for them.